找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: High-Risk IV Medications in Special Patient Populations; Sandra Kane-Gill,Joseph Dasta Book 2011 Springer-Verlag London Limited 2011 High

[復(fù)制鏈接]
查看: 17088|回復(fù): 35
樓主
發(fā)表于 2025-3-21 20:01:48 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書(shū)目名稱High-Risk IV Medications in Special Patient Populations
編輯Sandra Kane-Gill,Joseph Dasta
視頻videohttp://file.papertrans.cn/427/426747/426747.mp4
概述The Institute for Safe Medication Practices has developed a list of high-alert medications which are medications at a heightened risk for patient harm when used in error.No book has been published on
圖書(shū)封面Titlebook: High-Risk IV Medications in Special Patient Populations;  Sandra Kane-Gill,Joseph Dasta Book 2011 Springer-Verlag London Limited 2011 High
描述Critical Care Clinicians can use general drug references (Micomedex, Lexicomp) for data on dosing of high-alert medications in special patient populations but these references are not available to all healthcare clinicians, they are expensive and they are not specific to high-alert medications or critically ill patients. Doctors, nurses and pharmacists in the hospital setting will benefit from having one resource with all of this information. The purpose of this reference manual would be to guide critical care clinicians on dosing of high-alert medications in special patient populations. The most important feature of the book will be a summary of primary literature using tables when possible. This will be useful to readers because currently a reference book does not exist that guides clinicians in these difficult dosing decisions.
出版日期Book 2011
關(guān)鍵詞High Risk; Medication; Special Patient
版次1
doihttps://doi.org/10.1007/978-0-85729-606-1
isbn_softcover978-1-4471-5868-4
isbn_ebook978-0-85729-606-1
copyrightSpringer-Verlag London Limited 2011
The information of publication is updating

書(shū)目名稱High-Risk IV Medications in Special Patient Populations影響因子(影響力)




書(shū)目名稱High-Risk IV Medications in Special Patient Populations影響因子(影響力)學(xué)科排名




書(shū)目名稱High-Risk IV Medications in Special Patient Populations網(wǎng)絡(luò)公開(kāi)度




書(shū)目名稱High-Risk IV Medications in Special Patient Populations網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書(shū)目名稱High-Risk IV Medications in Special Patient Populations被引頻次




書(shū)目名稱High-Risk IV Medications in Special Patient Populations被引頻次學(xué)科排名




書(shū)目名稱High-Risk IV Medications in Special Patient Populations年度引用




書(shū)目名稱High-Risk IV Medications in Special Patient Populations年度引用學(xué)科排名




書(shū)目名稱High-Risk IV Medications in Special Patient Populations讀者反饋




書(shū)目名稱High-Risk IV Medications in Special Patient Populations讀者反饋學(xué)科排名




單選投票, 共有 1 人參與投票
 

1票 100.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用戶組沒(méi)有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 22:06:37 | 只看該作者
板凳
發(fā)表于 2025-3-22 03:08:14 | 只看該作者
地板
發(fā)表于 2025-3-22 06:53:51 | 只看該作者
Thrombolytics/Anticoagulants,f medical intervention, and 1.5% of patients experience prolonged hospitalization due to anticoagulant effects.. The most common types of medication errors regarding anticoagulant use are omission (29%), improper dose/quantity (27.9%), and prescribing (14.5%) errors..
5#
發(fā)表于 2025-3-22 12:25:21 | 只看該作者
6#
發(fā)表于 2025-3-22 15:33:01 | 只看該作者
7#
發(fā)表于 2025-3-22 17:57:53 | 只看該作者
Sandra Kane-Gill,Joseph DastaThe Institute for Safe Medication Practices has developed a list of high-alert medications which are medications at a heightened risk for patient harm when used in error.No book has been published on
8#
發(fā)表于 2025-3-22 23:33:09 | 只看該作者
http://image.papertrans.cn/h/image/426747.jpg
9#
發(fā)表于 2025-3-23 05:11:47 | 只看該作者
10#
發(fā)表于 2025-3-23 07:01:53 | 只看該作者
James C. Coons,Sandeep Devabhakthunin, Litzen, B?nder, Zwirn. In der Abteilung F?rberei wurde unter Beteiligung der direkt betroffenen Fachkr?fte ein Computersystem zur Farbdatenverarbeitung eingeführt. Traditionell verrichten die F?rber dieser Abteilung eine vorwiegend handwerkliche T?tigkeit, in der Geschick, Wissen um Rezepturen un
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-13 16:14
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
增城市| 烟台市| 涟源市| 革吉县| 巫溪县| 河池市| 凌海市| 陇川县| 文山县| 明溪县| 青铜峡市| 大同县| 阿图什市| 福海县| 高州市| 平谷区| 大足县| 乾安县| 西林县| 唐山市| 西昌市| 平顺县| 横山县| 汾西县| 蓝山县| 山丹县| 长垣县| 静海县| 上蔡县| 瓮安县| 宁河县| 新津县| 宜都市| 辽中县| 白玉县| 安远县| 桃园市| 喀喇| 梨树县| 泰顺县| 大邑县|